News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
871,030 Results
Type
Article (88045)
Company Profile (825)
Press Release (782138)
Multimedia
Podcasts (198)
Webinars (28)
Section
Business (233300)
Career Advice (4147)
Deals (39886)
Drug Delivery (151)
Drug Development (91442)
Employer Resources (205)
FDA (18404)
Job Trends (17430)
News (397993)
Policy (39976)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3014)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (151)
Alliances (56982)
ALS (183)
Alzheimer's disease (1804)
Antibody-drug conjugate (ADC) (352)
Approvals (18587)
Artificial intelligence (640)
Autoimmune disease (173)
Automation (39)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (490)
Bladder cancer (164)
Brain cancer (65)
Breast cancer (673)
Cancer (5107)
Cardiovascular disease (452)
Career advice (3572)
Career pathing (41)
CAR-T (311)
CDC (59)
Celiac Disease (2)
Cell therapy (845)
Cervical cancer (38)
Clinical research (77127)
Collaboration (1861)
Company closure (5)
Compensation (1186)
Complete response letters (74)
COVID-19 (2996)
CRISPR (99)
C-suite (897)
Cystic fibrosis (155)
Data (6371)
Decentralized trials (2)
Denatured (73)
Depression (153)
Diabetes (540)
Diagnostics (7252)
Digital health (49)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (310)
Drug pricing (227)
Drug shortages (36)
Duchenne muscular dystrophy (244)
Earnings (100272)
Editorial (65)
Employer branding (25)
Employer resources (174)
Events (135262)
Executive appointments (1041)
FDA (21639)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1579)
Gene editing (218)
Generative AI (68)
Gene therapy (685)
GLP-1 (1144)
Government (5454)
Grass and pollen (8)
Guidances (387)
Healthcare (20955)
HIV (64)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (300)
Immuno-oncology (65)
Indications (105)
Infectious disease (3288)
Inflammatory bowel disease (207)
Inflation Reduction Act (17)
Influenza (122)
Intellectual property (252)
Interviews (816)
IPO (17965)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (70)
Kidney cancer (17)
Labor market (94)
Layoffs (660)
Leadership (40)
Legal (10162)
Liver cancer (99)
Longevity (16)
Lung cancer (689)
Lymphoma (385)
Machine learning (45)
Management (66)
Manufacturing (871)
MASH (175)
Medical device (15049)
Medtech (15105)
Mergers & acquisitions (23006)
Metabolic disorders (1428)
Multiple sclerosis (170)
NASH (23)
Neurodegenerative disease (363)
Neuropsychiatric disorders (103)
Neuroscience (3153)
Neurotech (1)
NextGen: Class of 2026 (7709)
Non-profit (5113)
Now hiring (66)
Obesity (696)
Opinion (337)
Ovarian cancer (170)
Pain (218)
Pancreatic cancer (234)
Parkinson's disease (303)
Partnered (39)
Patents (515)
Patient recruitment (501)
Peanut (60)
People (66979)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23830)
Phase 2 (33473)
Phase 3 (25210)
Pipeline (5327)
Policy (341)
Postmarket research (3554)
Preclinical (10697)
Press Release (72)
Prostate cancer (252)
Psychedelics (57)
Radiopharmaceuticals (304)
Rare diseases (937)
Real estate (7442)
Recruiting (81)
Regulatory (29117)
Reports (67)
Research institute (2731)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (21)
RSV (85)
Schizophrenia (160)
Series A (262)
Series B (204)
Service/supplier (30)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (178)
Sponsored (48)
Startups (4335)
State (2)
Stomach cancer (20)
Supply chain (114)
Tariffs (101)
The Weekly (123)
Vaccines (1157)
Venture capital (98)
Weight loss (479)
Women's health (94)
Worklife (22)
Date
Today (146)
Last 7 days (683)
Last 30 days (2385)
Last 365 days (32845)
2026 (3341)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (92)
Alaska (7)
Arizona (345)
Arkansas (14)
Asia (51605)
Australia (9063)
California (11697)
Canada (3358)
China (1191)
Colorado (498)
Connecticut (507)
Delaware (352)
Europe (118584)
Florida (1721)
Georgia (375)
Hawaii (4)
Idaho (68)
Illinois (975)
India (72)
Indiana (550)
Iowa (24)
Japan (440)
Kansas (133)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1466)
Massachusetts (8614)
Michigan (364)
Minnesota (669)
Mississippi (6)
Missouri (141)
Montana (35)
Nebraska (29)
Nevada (127)
New Hampshire (86)
New Jersey (3141)
New Mexico (33)
New York (3090)
North Carolina (1631)
North Dakota (10)
Northern California (5613)
Ohio (359)
Oklahoma (23)
Oregon (55)
Pennsylvania (2335)
Puerto Rico (24)
Rhode Island (50)
South America (1664)
South Carolina (67)
South Dakota (1)
Southern California (4519)
Tennessee (178)
Texas (1847)
United States (42188)
Utah (352)
Vermont (1)
Virginia (294)
Washington D.C. (88)
Washington State (985)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
There are 871,030 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Evommune Soars as Dermatitis Treatment Rivals Dupixent in Mid-Stage Trial
The newly public Evommune shared data showing that EVO301, an IL-18 targeting protein, cleared symptoms comparably to Regeneron and Sanofi’s mega-blockbuster in a mid-stage atopic dermatitis clinical trial.
February 10, 2026
·
1 min read
·
Dan Samorodnitsky
Press Releases
HemoSonics’ Quantra Hemostasis System for Obstetric Procedures Named a 2026 Edison Awards Finalist
February 10, 2026
·
5 min read
Press Releases
Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
February 10, 2026
·
1 min read
Press Releases
Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial
February 10, 2026
·
7 min read
Press Releases
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
February 10, 2026
·
8 min read
Press Releases
Experic Announces the Appointment of Matthew Mollan, Ph.D. as Chief Executive Officer
February 10, 2026
·
3 min read
Press Releases
OrsoBio Announces Positive Topline Phase 2a Data for LXR Inverse Agonist TLC-2716 in Severe Hypertriglyceridemia and Metabolic Liver Disease
February 10, 2026
·
3 min read
Press Releases
ILiAD Biotechnologies Announces $115M Oversubscribed Series B Financing to Advance BPZE1 Pertussis Vaccine
February 10, 2026
·
4 min read
Press Releases
Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
February 10, 2026
·
2 min read
Press Releases
Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
February 10, 2026
·
1 min read
1 of 87,103
Next
